71673-18-2 Usage
Type
Synthetic anthracenedione derivative
Antineoplastic
Exhibits anti-cancer properties
DNA intercalation
Binds to DNA, causing structural changes
Topoisomerase II inhibition
Inhibits the enzyme topoisomerase II, leading to DNA damage
Immunosuppressive
Suppresses the immune system
Chemotherapy
Treats various cancers, including leukemia, breast cancer, and non-Hodgkin's lymphoma
Multiple sclerosis treatment
Used to manage symptoms of multiple sclerosis
Administration
Intravenous
Side Effects
May cause nausea, hair loss, and an increased risk of infection
Potency
Potent chemotherapeutic agent
Importance
Significant in the treatment of cancer and autoimmune diseases
Check Digit Verification of cas no
The CAS Registry Mumber 71673-18-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,6,7 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 71673-18:
(7*7)+(6*1)+(5*6)+(4*7)+(3*3)+(2*1)+(1*8)=132
132 % 10 = 2
So 71673-18-2 is a valid CAS Registry Number.
InChI:InChI=1/C30H38N2O4/c33-17-21-11-7-19(8-12-21)15-31-25-5-1-3-23-27(25)30(36)24-4-2-6-26(28(24)29(23)35)32-16-20-9-13-22(18-34)14-10-20/h1-6,19-22,31-34H,7-18H2